Treasury yields also climbed in the bond market in a signal investors are feeling less worried about the economy after a report showed fewer U.S. workers applied for unemployment benefits last week.
The Indianapolis-based drugmaker said revenue increased 36% in the quarter, to $11.3 billion. Zepbound, the popular obesity drug that launched in December, crossed into blockbuster territory, with sales of $1.23 billion in the quarter.
Novo is vying with Indianapolis-based Lilly for supremacy in the pharmaceutical industry’s fastest-growing new business, obesity drugs. The market is expected to reach $130 billion by the end of the decade.
Victoza yielded mixed results in a mid-stage study of Alzheimer’s disease, failing to meet its primary goal while showing hints that larger trials of similar drugs may be successful.
After spending the last week on a trade trip in Australia and Singapore, Indiana Gov. Eric Holcomb told reporters he plans to “maximize” his final months in office.
Researchers reported Sunday that new blood tests were 91% accurate in detecting Alzheimer’s disease, far more accurate than a diagnosis from primary care doctors and specialists.
The spotlight is turning to Indianapolis-based Eli Lilly and Co. as the next possible member of the so-called “Trillion-Dollar Club,” based on the drugmaker’s climbing stock price and swelling demand for its treatments for diabetes, obesity and other diseases.
We want your help finding our next group of extraordinary leaders to honor for our Women of Influence program. Go to IBJ.com/nominations to get more details and fill out the nomination form. Nominations are due Aug. 2.
It was a mating dance that lasted more than three years. At the end, Eli Lilly and Co. wound up buying a Massachusetts-based biotech developing treatments for inflammatory bowel disease for $3.2 billion.
Shortages of brand-name drugs made by Novo and Eli Lilly and Co. have allowed pharmacies to make what are essentially copies, and telehealth companies like Hims are selling them to patients at a steep discount.
DEI efforts remain popular with the Indiana Chamber of Commerce and some prominent members of the Hoosier business community even as companies elsewhere back away from what has become a culture war flashpoint.
This year’s list introduces nearly 70 new individuals, encompassing corporate executives, philanthropic leaders and notable personalities making significant contributions in Indiana.
Indiana is home to 32 Australian businesses and two Singaporean-owned businesses, and several Indiana-based companies do business in either Australia and Singapore, or both.
The Roche drug is a once-daily pill, compared to Lilly’s tirzepatide, sold under the brand names Mounjaro (for diabetes) and Zepbound (for obesity), which is a once-weekly shot.
State and corporate leaders believe a tech park taking shape on the western edge of downtown could be a launchpad for health sciences innovation and commercialization as part of the state’s ambitious economic development portfolio.
AnalytiXIN is a collaborative effort between major Indiana corporations, industry groups and academic institutions to share information on data sciences, including digital, AI and advanced analytic capabilities.
